Results 1 to 2 of 2

$1 billion available for emerging growth life sciences companies through health care reform

USA - April 12 2010 The recently enacted landmark health care reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act, appropriates up to $1 billion in tax credits and cash grants for small and mid-sized life sciences companies to defray the costs of investment in qualifying therapeutic discovery projects undertaken in 2009 and 2010.

Jeffrey A. Baumel, Victor H. Boyajian, L. Robert Guenthner, Ira L. Kotel

Bill to allow biosimilars introduced in the House

USA - March 16 2009 A bill that would allow the Food and Drug Administration (FDA) to approve similar versions of already-approved biologic drugs was introduced on March 11, 2009, by House Energy and Commerce Committee Chairman Henry Waxman (D-Calif.), and Reps. Frank Pallone (D-N.J.), Nathan Deal (R-Ga.), and Jo Ann Emerson (R-Mo.).

Susan DeSanti